Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Revital Bruchim Bar Sade"'
Autor:
Galit Ichezkel-Hirsch, Baruch Modan, Revital Bruchim Bar-Sade, Angela Chetrit, Eitan Friedman, Ruth Gershoni-Baruch, Walter H. Gotlieb, Ronit Shiri-Sverdlov, Shulamith Rizel
Publikováno v:
Public Health Genomics. 4:50-55
Background: In Jewish individuals of Ashkenazi (East European) decent, three predominant mutations, 185 delAG and 5382insC (BRCA1) and 6174delT (BRCA2), seem to account for a substantial portion of germline mutations in high-risk breast/ovarian cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::263051a5269adc71ccd9494a0e02763d
https://doi.org/10.1159/000051156
https://doi.org/10.1159/000051156
Autor:
Arie Figer, Meora Feinmesser, Ronit Shiri Sverdlov, Eitan Friedman, Ruth Gershoni Baruch, Iris Barshack, Galit Hirsh-Yehezkel, Ephrat Dagan, Revital Bruchim Bar Sade
Publikováno v:
Genetic Testing. 4:313-317
Male breast cancer is a rare disorder, and little is known about the molecular mechanisms associated with the tumorigenic process. We genotyped 31 Jewish Israeli males with breast cancer for the predominant Jewish BRCA1 (185delAG, 5382InsC) and BRCA2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a028850ae9bc933d314804afa42483b
https://doi.org/10.1089/10906570050501579
https://doi.org/10.1089/10906570050501579
Autor:
Revital Bruchim Bar Sade, Limor Green, Samario Haitchick, Eitan Friedman, Peter J. Oefner, Anna Kruglikova, Efrat Dagan, Robert M.W. Hofstra, Rizel S, Ruth Gershoni Baruch, Inge M. Mulder, Ronit Shiri-Sverdlov, Ziad Abdeen, Boleslaw Goldman, Moshe Z. Papa, Teresa Wagner
Publikováno v:
Human Mutation. 16:491-501
In Ashkenazi (East European) Jews, three predominant mutations in BRCA1 (185delAG and 5382insC) and BRCA2 (6174-delT) account for the majority of germline mutations in high risk breast and/or ovarian cancer families. Among non-Ashkenazi Jews, the 185
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac53abe60e951e9b3e7f301f7f30d6f7
https://doi.org/10.1002/1098-1004(200012)16:6<491::aid-humu6>3.0.co
https://doi.org/10.1002/1098-1004(200012)16:6<491::aid-humu6>3.0.co
Autor:
Eitan Friedman, Juri Kopolovic, Ilya Novikov, Walter H. Gotlieb, Galit Hirsh-Yechezkel, Anna Kruglikova, Baruch Modan, Moshe Inbar, Ben Davidson, Gilad Ben-Baruch, Revital Bruchim Bar-Sade
Publikováno v:
JNCI Journal of the National Cancer Institute. 90:995-1000
Background: Germline mutations in the BRCA1 and BRCA2 genes are known to be associated with an increased risk of breast and epithelial ovarian cancers. Two specific mutations, 185delAG-BRCA1 and 6174delT-BRCA2, have been detected in a substantial pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee4cdcca4d9091097900186e4af4af19
https://doi.org/10.1093/jnci/90.13.995
https://doi.org/10.1093/jnci/90.13.995
Autor:
Galit Hirsh-Yechezkel, Ruth Gershoni-Baruch, Revital Bruchim Bar-Sade, Eva Gak, Livia Theodor, Shulamit Risel, Moshe Z. Papa, Eitan Friedman, Baruch Modan, Gilad Ben-Baruch, Anna Kruglikova, Ilya Novikov
Publikováno v:
Human Molecular Genetics. 7:801-805
The 185delAG mutation in BRCA1 is detected in Ashkenazi Jews both in familial breast and ovarian cancer and in the general population. All tested Ashkenazi mutation carriers share the same allelic pattern at the BRCA1 locus. Our previous study showed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704cfd72bf26455e47a2c81454c0dcbe
https://doi.org/10.1093/hmg/7.5.801
https://doi.org/10.1093/hmg/7.5.801
Autor:
Iris Goldberg, David Ben-Dor, Eitan Friedman, Anna Kruglikova, Ronit Shiri-Svredlov, Frieda Barak, Revital Bruchim Bar Sade
Publikováno v:
American Journal of Medical Genetics. 98:277-279
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4272ca7ccf1262aac7c3a97dfec5439
https://doi.org/10.1002/1096-8628(20010122)98:3<277::aid-ajmg1082>3.0.co
https://doi.org/10.1002/1096-8628(20010122)98:3<277::aid-ajmg1082>3.0.co
Autor:
Eitan Friedman, Revital Bruchim Bar Sade, Arie Figer, Moshe Z. Papa, Shulamit Rizel, Angela Chetrit, Dov Flex
Publikováno v:
European journal of cancer (Oxford, England : 1990). 42(5)
The aim of this study was to compare reproductive factors, use of oral contraceptives (OC) and hormone replacement therapy (HRT) in consecutive Jewish Ashkenazi breast cancer patients, with and without BRCA1/BRCA2 mutations. Jewish Israeli women with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7aae89dbb2979b91d68a97222be8f6a
https://pubmed.ncbi.nlm.nih.gov/16464572
https://pubmed.ncbi.nlm.nih.gov/16464572
Autor:
Arie, Figer, Yael Patael, Karasik, Ruth Gershoni, Baruch, Angela, Chetrit, Moshe Z, Papa, Revital Bruchim Bar, Sade, Shulamith, Rizel, Eitan, Friedman, Shulamith, Riezel
Publikováno v:
The Israel Medical Association journal : IMAJ. 4(10)
Genes that confer mild or moderate susceptibility to breast cancer may be involved in the pathogenesis of sporadic breast cancer, modifying the phenotypic expression of mutant BRCA1/BRCA2 alleles. An attractive candidate is the insulin-like growth fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::878c17fe97f46d79ca3e23a720e1ed23
https://pubmed.ncbi.nlm.nih.gov/12389335
https://pubmed.ncbi.nlm.nih.gov/12389335
Autor:
Ronit Shiri-Sverdlov, Peter Oefner, Limor Green, Ruth Gershoni Baruch, Teresa Wagner, Anna Kruglikova, Samario Haitchick, Robert M.W. Hofstra, Moshe Z. Papa, Inge Mulder, Shulamit Rizel, Revital Bruchim Bar Sade, Efrat Dagan, Ziad Abdeen, Boleslaw Goldman, Eitan Friedman
Publikováno v:
Human mutation. 16(6)
In Ashkenazi (East European) Jews, three predominant mutations in BRCA1 (185delAG and 5382insC) and BRCA2 (6174delT) account for the majority of germline mutations in high-risk breast and/or ovarian cancer families. Among non-Ashkenazi Jews, the 185d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50217e7a2af7784ed2664ce53607e3fb
https://pubmed.ncbi.nlm.nih.gov/11102978
https://pubmed.ncbi.nlm.nih.gov/11102978
Autor:
G. Hirsh Yechezkel, Moshe Z. Papa, Gideon Rechavi, Eitan Friedman, Baruch Modan, Anna Kruglikova, Ronit Shiri-Sverdlov, Shulamit Risel, Livia Theodor, Gilad Ben-Baruch, Revital Bruchim Bar-Sade
Publikováno v:
Scopus-Elsevier
British Journal of Cancer
British Journal of Cancer
Unique germline mutations in BRCA1 and BRCA2 account for inherited predisposition to breast and ovarian cancer in high-risk families. In Jewish high-risk individuals of Ashkenazi (east European) descent, three predominant mutations, 185delAG and 5382
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a45486d209274be69441bf01cffa34
http://www.scopus.com/inward/record.url?eid=2-s2.0-17644439776&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-17644439776&partnerID=MN8TOARS
